MyMyelomaTeam

Yes, many people have undergone CAR-T cell therapy for multiple myeloma. Here’s what you can expect:

1. Preparation:
- Lymphodepletion: Before receiving CAR-T cells, you may undergo a round of chemotherapy to remove old T cells and make room for the new ones.

2. Treatment Process
- Infusion: The CAR-T cells are Show Full Answer

Yes, many people have undergone CAR-T cell therapy for multiple myeloma. Here’s what you can expect:

1. Preparation:
- Lymphodepletion: Before receiving CAR-T cells, you may undergo a round of chemotherapy to remove old T cells and make room for the new ones.

2. Treatment Process:
- Infusion: The CAR-T cells are returned to your body through an intravenous (IV) infusion.
- Hospital Stay: You may need to stay in the hospital for several weeks to monitor the treatment's effectiveness and manage any side effects.

3. Side Effects:
- Common side effects include infections, muscle aches, diarrhea, nausea, swelling, fever, cough, headache, and loss of appetite.
- Cytokine Release Syndrome (CRS): This condition can develop when T cells are activated and produce a lot of cytokines. It’s important to discuss potential side effects with your doctor.

4. Post-Treatment:
- Monitoring: Even after being discharged, you may need to stay close to the treatment center for a month or more in case any complications occur.

5. Support:
- MyMyelomaTeam: This social network connects over 11,000 people with multiple myeloma and their loved ones, providing a platform to share experiences and advice.

Always discuss the risks and benefits with your healthcare team to make an informed decision.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

CAR-T Cell Therapy for Multiple Myeloma: What Is It? | MyMyelomaTeam